A Study of the Safety, Blood Levels and Biological Effects of GBT440 in Healthy Subjects and Subjects With Sickle Cell Disease
Clinical trial NCT02285088 · COMPLETED
Trial details
- NCT number
- NCT02285088
- Sponsor
- Global Blood Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-03-01
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.